logo
  • Home
  • News
Menu

PharmEasy buys 66% stake in Thyrocare

Home / Stock Analysis / PharmEasy buys 66% stake in Thyrocare
Article feature image

PharmEasy buys 66% stake in Thyrocare

25 Jun Stock Analysis

Online pharmacy PharmEasys parent will buy a 66.1% stake in diagnostic chain Thyrocare Technologies for 4,546 crore, in a sign that Indians are increasingly using mobile apps for their healthcare needs.
Docon Technologies Pvt. Ltd, a unit of PharmEasys…

Click here to view the original article.

Tags:
Global, Livemint
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

1585186710114.jpeg
+

Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation in Focus After Strong Share Price Gains and Growth Surge

11 Oct Stock Analysis
1585186680358.jpeg
+

A Look at LGI Homes (LGIH) Valuation Following Recent Share Price Declines

11 Oct Stock Analysis

recent post

  • 1585186710114.jpeg

    Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation in Focus

    Oct 11 2025
  • 1760172281_articleshow.jpg

    Crypto sees record $19 billion wipeout

    Oct 11 2025
  • 1585186680358.jpeg

    A Look at LGI Homes (LGIH)

    Oct 11 2025
  • 1760171319_0x0.jpg

    ‘Trump Surprise’ Triggers Huge Crypto ‘Flash

    Oct 11 2025
  • 1585187425151.jpeg

    Assessing News Corp (NWSA) Valuation as

    Oct 11 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.